Cart
sales@molnova.com
Eflornithine hydrochloride Monohydrate
CAS No. 96020-91-6
Eflornithine hydrochloride Monohydrate( DFMO | Eflornithine )
Catalog No. M16851 CAS No. 96020-91-6
Eflornithine hydrochloride, hydrate (DFMO; MDL-71782) is a drug found to be effective in the treatment of facial hirsutism.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 50MG | 27 | In Stock |
|
| 100MG | 38 | In Stock |
|
| 200MG | 52 | In Stock |
|
| 500MG | 112 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameEflornithine hydrochloride Monohydrate
-
NoteResearch use only, not for human use.
-
Brief DescriptionEflornithine hydrochloride, hydrate (DFMO; MDL-71782) is a drug found to be effective in the treatment of facial hirsutism.
-
DescriptionEflornithine hydrochloride, hydrate (DFMO; MDL-71782) is a drug found to be effective in the treatment of facial hirsutism.(In Vivo):Eflornithine is the only new molecule registered for the treatment of human African trypanosomiasis over the last 50 years. It is the drug used mainly as a back-up for melarsoprol refractory Trypanosoma brucei gambiense cases. In subjects with excessive, unwanted facial hair, eflornithine 15% cream is superior to placebo in reducing hair growth. After 24 weeks' treatment, 58% of eflornithine and 34% of placebo subjects have at least some improvement in facial hirsutism. The hair growth inhibitory activity of eflornithine is significantly enhanced when the eflornithine cream is applied onto a mouse skin area pretreated with microneedles. Treatment of coarctation hypertensive rats with eflornithine results in a normalization of the contractile intensity to KCI and norepinephrine and relaxations to acetylcholine by 14 days of hypertension.
-
In Vitro——
-
In VivoEflornithine is the only new molecule registered for the treatment of human African trypanosomiasis over the last 50 years. It is the drug used mainly as a back-up for melarsoprol refractory Trypanosoma brucei gambiense cases. In subjects with excessive, unwanted facial hair, eflornithine 15% cream is superior to placebo in reducing hair growth. After 24 weeks' treatment, 58% of eflornithine and 34% of placebo subjects have at least some improvement in facial hirsutism. The hair growth inhibitory activity of eflornithine is significantly enhanced when the eflornithine cream is applied onto a mouse skin area pretreated with microneedles. Treatment of coarctation hypertensive rats with eflornithine results in a normalization of the contractile intensity to KCI and norepinephrine and relaxations to acetylcholine by 14 days of hypertension.
-
SynonymsDFMO | Eflornithine
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaOther Indications
-
Indication——
Chemical Information
-
CAS Number96020-91-6
-
Formula Weight236.64
-
Molecular FormulaC6H15ClF2N2O3
-
Purity>98% (HPLC)
-
SolubilitySoluble in DMSO
-
SMILESO.Cl.NCCCC(N)(C(F)F)C(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Mohammed A, et al. Y Prev Res (Phila). 2014 Dec;7(12):1198-209.
molnova catalog
related products
-
5,7-dimethoxy-2-benz...
5,7-dimethoxy-2-benzofuran-1(3H)-one (5,7-dimethoxyphthalide) is a phthalide isolated from Italian waxflower with good anti-inflammatory activity.
-
BAY-43-9695
BAY-43-9695 is a non-nucleoside compound with anti-human cytomegalovirus (HCMV) activity. It is the major metabolite of BAY-38-4766.
-
Bruceoside A
Bruceoside A could be transformed into the potent anticancer component brusatol in vivo, rather than its direct deglycosylated metabolite bruceosin.
